Search Results
Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast Cancer
Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer
Dr. Pegram Discusses the Use of Neratinib in HER2+ Breast Cancer
Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer
Dr. Pegram on Pertuzumab and Trastuzumab in Breast Cancer
Dr. Pegram on Challenges Facing the Treatment of HER2-Positive Breast Cancer
Dr. Pegram on Neoadjuvant Treatments for HER2-Postive Breast Cancer
Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast Cancer
Dr. Hamilton on FDA Approval of Adjuvant Pertuzumab Regimen in HER2+ Early Breast Cancer
Dr. Valdes-Albini on the FDA Approval of Adjuvant Pertuzumab in HER2+ Breast Cancer
Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast Cancer
Dr. Mark Pegram on Combining Trastuzumab and Pertuzumab
